Document is current

Article History

Received: 19 September 2025

Revised: 8 January 2026

Accepted: 9 January 2026

First Online: 1 April 2026

Ethical approval

: Ethics approvals were obtained from the University of Calgary Conjoint Health Research Ethics Board (REB22-0803), Ottawa Hospital Research Institute (Ethics ID: 20220590-01T) and Clinical Trials Ontario (CTO-4064). All participants provided informed consent electronically prior to beginning the survey.

: Some portions of this submission (e.g., refinement of summary paragraphs, and language editing for clarity and conciseness) were supported using OpenAI’s ChatGPT, based on the GPT-4 model (ChatGPT, version GPT-4, OpenAI Inc., ). All content was reviewed, verified, and edited by the authors to ensure accuracy, originality, and appropriateness for academic publication. No data analysis, interpretation of results, or generation of original scientific content was conducted solely by the AI tool.

: All authors declare they have no potential conflict of interest. Tetyana Kendzerska and Andrea S. Gershon are supported by the PSI (Physicians’ Services Incorporated) foundation. Outside of the submitted work, Sachin R. Pendharkar has received honoraria and grant funding from Jazz Pharmaceuticals. Outside of the submitted work, Marcus Povitz has received a fellowship grant from Paladin Labs and contract research from Jazz Pharmaceuticals. Outside of the submitted work, Najib Ayas has received a speaker honorarium from ResMed and has been a consultant with EISAI, Jazz, Cerebra, Eli Lilly, and Powell Mansfield. Outside of the submitted work, Marta Kaminska is a consultant for Biron Soins du Sommeil; she also reported research funding from Fisher & Paykel outside of the submitted work. Outside of the submitted work, the University of California San Diego (UCSD) Sleep Medicine Center received a donation from ResMed.